Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy.

ABSTRACT:

Importance

The study team previously showed that maternal mRNA COVID-19 vaccination during pregnancy confers protection against SARS-CoV-2 infection and COVID-19-related hospital admission in newborns and young infants. In this study, the study team evaluated newborn and early infant safety outcomes following maternal messenger RNA (mRNA) COVID-19 vaccination during pregnancy, for which there is limited comparative epidemiological evidence.

Objective

To determine if maternal mRNA COVID-19 vaccination during pregnancy is associated with adverse newborn and early infant outcomes.

Design, setting, and participants

This population-based retrospective cohort study took place in Ontario, Canada, using multiple linked health administrative databases. Singleton live births wi

SUBMITTER: Jorgensen SCJ 

PROVIDER: S-EPMC10594175 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature